The synergy of multiphoton fluorescence imaging (MP-FI)
and magnetic
resonance imaging (MRI) provides an imaging platform with high resolution
and unlimited penetration depth for early disease detection. Herein,
two kinds of terpyridine–Mn(II) complexes (FD–Mn–O
2
NO and FD–Mn–FD) possessing seven and six coordination modes, respectively, were
designed rationally for photodynamic therapy (PDT) guided by MP-FI/MRI.
The complexes obtain different multiphoton fluorescence/magnetic resonance
properties by adjusting the number of terpyridine ligands. Among them, FD–Mn–FD exhibits the following superiorities:
(1) The optimal three-photon excitation wavelength of FD–Mn–FD falls at 1450 nm (NIR-II), which brings high sensitivity and deep
tissue penetration in MP-FI. (2) FD–Mn–FD has effective longitudinal relaxation efficiency (r
1 = 2.6 m M–1 s–1),
which can be used for T
1-weighted MRI,
overcoming the problems of limited tissue penetration depth and low
spatial resolution. (3) FD–Mn–FD generates
endogenous 1O2 under irradiation by 808 nm light,
thereby enhancing the PDT effect in vitro and in vivo. To the best
of our knowledge, the complex FD–Mn–FD is
the first complex to guide PDT through MP-FI/MRI, providing a blueprint
for accurate and effective early detection and timely treatment of
the complex in the early stages of cancer.